alexa Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Huser W, Bartram C, BartramWunn E, Tlle T, Huser W, Bartram C, BartramWunn E, Tlle T

Abstract Share this page

Abstract OBJECTIVE: The objectives of the study were to determine the impact of nocebo effects on adverse events (AEs) in drug trials in fibromyalgia syndrome (FMS) and painful diabetic peripheral neuropathy (DPN). METHODS: MEDLINE, CENTRAL, SCOPUS, and the databases of the U.S. National Institutes of Health and the Pharmaceutical Research and Manufacturers of America were searched until December 31, 2010. Randomized controlled trials with a parallel design of any drug therapy compared with pharmacological placebo in patients with FMS and DPN were included. Pooled estimates of nocebo effects (number of patients with at least 1 AE and dropping out due AEs) were calculated for placebo and true drug groups by a random effects model. RESULTS: Fifty-eight FMS (62 DPN) trials included a total of 5065 (5095) patients in placebo groups. The quality of reporting the assessment strategy of AEs was poor in most trials. The pooled estimate of the event rate drop out rate due to AEs in placebo groups was 9.6 [95\% confidence control (CI): 8.6-10.7] in placebo and 16.3 (95\% CI: 14.1-31.2) in true drug groups of FMS trials and was 5.8 (95\% CI: 5.1-6.6) in placebo and 13.2 (95\% CI: 10.7-16.2) in true drug groups of DPN trials. Nocebo effects accounted for 72.0\% (44.9) of the drop outs in true drug groups in FMS (DPN). DISCUSSION: Nocebo effects substantially accounted for AEs in drug trials of FMS and DPN. Standards to assess and report AEs should be defined by regulatory agencies. Strategies to minimize nocebo effects in both clinical trials and clinical practice should be developed. This article was published in Clin J Pain and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version